Navigation Links
Fingerprints May Vanish With Cancer Drug
Date:5/27/2009

Travelers are warned of side effect that could hamper immigration checks

WEDNESDAY, May 27 (HealthDay News) -- The widely used cancer drug capecitabine can cause people to lose their fingerprints, which could lead to problems when they're trying to enter the United States, an oncologist warns.

Dr. Eng-Huat Tan, a senior consultant in medical oncology at the National Cancer Centre in Singapore, said he now advises people taking capecitabine to carry a doctor's letter when traveling.

In a letter published online Wednesday in the Annals of Oncology, Tan described the experience of a 62-year-old cancer patient taking capecitabine who was held for four hours by U.S. immigration officials because his fingerprints had vanished. The man was eventually allowed into the country.

Tan said that several other cancer patients have reported the loss of fingerprints on their blog sites and some have also said they've had problems entering the United States.

Capecitabine -- used to treat head and neck cancers, breast, stomach and colorectal cancers, among others -- can cause a side effect called hand-foot syndrome. This is a chronic inflammation of the palms of the hands or soles of the feet that can cause the skin to peel, bleed and develop ulcers or blisters, Tan said.

"This can give rise to eradication of fingerprints with time," he explained.

"In summary, patients taking long-term capecitabine may have problems with regards to fingerprint identification when they enter the United States' ports or other countries that require fingerprint identification and should be warned about this," Tan wrote.

"It is uncertain when the onset of fingerprint loss will take place in susceptible patients who are taking capecitabine," Tan said. "However, it is possible that there may be a growing number of such patients as 'Mr. S.' who may benefit from maintenance capecitabine for disseminated malignancy. These patients should prepare adequately before traveling to avert the inconvenience that 'Mr. S.' was put through."

Tan recommended that people taking capecitabine carry a letter from their oncologist.

"My patient subsequently traveled again with a letter from us, and he had fewer problems getting through" immigration, Tan said.

More information

The U.S. National Library of Medicine has more about capecitabine.



-- Robert Preidt



SOURCE: Annals of Oncology, news release, May 27, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Cancer drug causes patient to lose fingerprints and be detained by US immigration
2. DNA Fingerprints Predict Brain Disorders
3. Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research
4. Berkeley Lab scientist co-leads breast cancer dream team
5. $18 million awarded to TGen and University of Pennsylvania for pancreatic cancer research
6. New Survey Highlights Growing Concern About Risk of Infection in Cancer Patients and Emerging Antibiotic Resistance
7. Gene Mutation May Up Risks of Endometrial Cancer
8. U.S. Cancer Death Rates Continue to Fall
9. Hanes(R) Teams up with Susan G. Komen for the Cure(R) and Actress Sarah Chalke to Comfort Those Affected by Breast Cancer
10. Predicting higher risk for prostate cancer diagnosis
11. Risks Remain for Childhood Cancer Survivors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fingerprints May Vanish With Cancer Drug
(Date:2/8/2016)... ... February 08, 2016 , ... Tingley Rubber Corporation , ... provide its range of unique and advantaged protective solutions to a growing ... provide bilingual customer service and marketing support. A new distribution center in Brampton, ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... ... Indianapolis, IN metro area, has selected the latest beneficiary of their ongoing community ... dedicated to preventing bullying in area schools. Donations are now being accepted at: ...
(Date:2/8/2016)... ... ... Delta Dental of California and its affiliated companies announced today that it ... recently retired as president and CEO of Delta Dental of California and its affiliates ... , helped lead the effort to raise funds for studies to strengthen pancreatic cancer ...
(Date:2/8/2016)... AUSTIN (PRWEB) , ... February 08, 2016 , ... Remember ... next time. , According to Perry A~, author of “Calcium Bentonite Clay” the ... a key role in balancing and detoxifying the body. , A former motivational speaker, ...
(Date:2/8/2016)... ... , ... FileHold's document management software has been implemented by ... environment for FileHold software that is pay per user subscription-based and also does ... FileHold web services API. DocuSyst also advises clients on fully functioning back up ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... Feb. 8, 2016  Dynatronics Corporation (NASDAQ: ... medical devices and rehabilitation equipment for the physical ... Denver Broncos, football team for winning the 2016 ... , Chairman and Chief Executive Officer.  "The Broncos ... look forward to enhancing their athletic achievements with ...
(Date:2/8/2016)... BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA:CTIC) today announced ... Food and Drug Administration (FDA) on February 4, 2016, ... on the clinical studies being conducted under the Company,s ... hold impacts part of the clinical work currently being ... clinical trials. --> ...
(Date:2/5/2016)... , Feb. 5, 2016  Syneron Medical Ltd. ... device company, announced today that William Griffing ... America, is scheduled to participate in the Leerink ... on February 11, 2016 in New ... institutional investors to meet with the Mr. Griffing ...
Breaking Medicine Technology: